The bears are targeting trendline support as USDJPY is currently at 141.365.

0
189

The bears are targeting trendline support as USDJPY is currently at 141.365.

Follow Our Twitter

Join Our Telegram Group


This is a premium post.
[s2If !current_user_can(access_s2member_level4)]Please register for FREE REGISTER to read full post below containing analysis. In case of any error or you think you are not able to read the full post below, please email us at support#nehcap.com [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • USD/JPY bears eye a run towards trendline support.
  • The 38.2% Fibo is exposed on the daily chart.
  • The US Dollar index moved up on Tuesday and sank the Yen as investors weighed the US interest rate outlook ahead of Federal Reserve Chair Jerome Powell’s congressional testimony. US Treasury yields also eased but USD/JPY fell to 141.21 from a high of 142.25 nonetheless. The following illustrates that there is further downside potential in the correction as anticipated in prior analysis, USD/JPY Price Analysis: Bulls throwing in the towel, 38.2% Fibo eyed?,

    The bears were anticipated to move in which left the Fibonacci scale open for mitigation to the downside and move to test near-term trendline support.

    Bulls are yet to be seen which leaves scope for further downside with the 38.2% Fibonacci still in tact and vulnerable to a test, exposing 141 the figure for the day ahead.

    [/s2If]
    Nehcap Expert Advisor
    The NEHCAP MT4 EA is high quality professional trading system geared to generate returns without using GRID or martingales. Each trade has strict risk per trade parameter. The pairs under management include EURUSD, GBPUSD, AUDCAD, AUDNZD,GBPAUD, EURAUD, EURCAD, CHFJPY and many more.
    The system is trading live: LIVE ACCOUNT TRACKING
    You can run it free. Apply for a free trial and track our account. Buy the system or use profit share mechanism to generate returns on your MT4.
    Join Our Telegram Group

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here